Missing/wrong data?
Log in to edit
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study
scientific article
Author/s
author: Isabelle Poizot-Martin, Christine Katlama, Adriano Lazzarin, Bonaventura Clotet Sala, Vicente Soriano, Joseph J Eron, Mounir Ait-Khaled
Work details
Publication date
December 7, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.